# Clearone Inc: overview CLRO · Nasdaq · CIK 840715 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/clro.md) · [Financials](/companies/clro/financials.md) · [Filings](/companies/clro/filings.md) · [Insiders](/companies/clro/insiders.md) Latest reported revenue: [$0](/filings/0001753926-26-001521.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0001753926-26-001521). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [0.0](/filings/0001753926-25-001796.md) | [0.0 d](/filings/0001753926-26-000600.md) | [0.0](/filings/0001753926-26-000897.md) | [0.0](/filings/0001753926-26-001521.md) | [0.0](/filings/0001753926-25-001796.md) | [0.0 d](/filings/0001753926-26-000600.md) | [0.0](/filings/0001753926-26-000897.md) | [0.0](/filings/0001753926-26-001521.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [(1.29)](/filings/0001753926-25-001796.md) | not reported | [(1.71)](/filings/0001753926-26-000897.md) | [(2.64)](/filings/0001753926-26-001521.md) | [(7.92)](/filings/0001753926-25-001796.md) | not reported | [(0.18)](/filings/0001753926-26-000897.md) | [(0.34)](/filings/0001753926-26-001521.md) | | Free cash flow | $k | [(1,873) d](/filings/0001753926-24-001912.md) | [(1,582) d](/filings/0001753926-25-000516.md) | [(1,456)](/filings/0001753926-25-000847.md) | [(1,129) d](/filings/0001753926-25-001345.md) | [(754) d](/filings/0001753926-25-001796.md) | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment; Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [29.0](/filings/0001753926-23-000346.md) | [25.2](/filings/0001753926-24-000656.md) | [18.7](/filings/0001753926-25-000516.md) | [0.0](/filings/0001753926-26-000600.md) | [0.0](/filings/0001753926-26-000600.md) | | Gross margin | % | [41.1%](/filings/0001753926-23-000346.md) | [37.5%](/filings/0001753926-24-000656.md) | [34.0%](/filings/0001753926-25-000516.md) | not reported | not reported | | Operating margin | % | [(25.9%)](/filings/0001753926-23-000346.md) | [(28.7%)](/filings/0001753926-24-000656.md) | [(36.2%)](/filings/0001753926-25-000516.md) | not reported | not reported | | Net margin | % | [(26.6%)](/filings/0001753926-23-000346.md) | [81.6%](/filings/0001753926-24-000656.md) | [(3.0%)](/filings/0001753926-25-000516.md) | not reported | not reported | | Diluted EPS | $ per share | [(0.39)](/filings/0001753926-23-000346.md) | [0.83](/filings/0001753926-24-000656.md) | [(0.02)](/filings/0001753926-25-000516.md) | [(5.61)](/filings/0001753926-26-000600.md) | [(14.77)](/filings/0001753926-26-000600.md) | | Free cash flow | $m | [(4.6)](/filings/0001753926-23-000346.md) | [(4.2)](/filings/0001753926-24-000656.md) | [54.3](/filings/0001753926-25-000516.md) | [(6.3)](/filings/0001753926-25-000516.md) | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment; Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/clro/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Shay Capital LLC](/funds/1723643.md) | 2026-06-30 | $151.5k | 45,486 | | Reduced −10,114 | | [T3 Companies, LLC](/funds/2052441.md) | 2026-06-30 | $99.9k | 30,000 | | Unchanged | | [ALBION FINANCIAL GROUP /UT](/funds/1054677.md) | 2026-06-30 | $48.2k | 14,465 | | Unchanged | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $36.1k | 10,834 | | Reduced −2,991 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $17.5k | 5,258 | | Unchanged | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $8.0k | 2,395 | | Unchanged | | [Tower Research Capital LLC (TRC)](/funds/1533421.md) | 2026-06-30 | $3.9k | 1,161 | | Added +522 | | [FINANCIAL CONSULATE, INC](/funds/1624510.md) | 2026-06-30 | $50 | 15 | | Unchanged | | [SBI Securities Co., Ltd.](/funds/1851815.md) | 2026-06-30 | $33 | 10 | | Unchanged | | [Caitong International Asset Management Co., Ltd](/funds/1963355.md) | 2026-06-30 | $3 | 1 | | New +1 | ## Recent filings [All 798 filings](/companies/clro/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-15 | 01:08 ET | [8-K](/filings/0001753926-26-001940.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001753926-26-001940 | | 2026-10-13 | 10:01 ET | [8-K](/filings/0001753926-26-001927.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001753926-26-001927 | | 2026-09-04 | 20:46 ET | [S-1/A](/filings/0001753926-26-001724.md) | Registration statement, amended | 0001753926-26-001724 | | 2026-08-26 | 20:30 ET | [8-K](/filings/0001753926-26-001641.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001753926-26-001641 | | 2026-08-14 | 20:31 ET | [10-Q](/filings/0001753926-26-001521.md) | Quarterly report, period 2026-06-30 | 0001753926-26-001521 | | 2026-08-11 | 21:21 ET | [8-K](/filings/0001753926-26-001428.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001753926-26-001428 | | 2026-08-10 | 20:47 ET | [S-1](/filings/0001753926-26-001386.md) | Registration statement | 0001753926-26-001386 | | 2026-08-06 | 21:52 ET | [SCHEDULE 13D/A](/filings/0001493152-26-036428.md) | Ownership report, active investor, amended | 0001493152-26-036428 | | 2026-08-05 | 21:01 ET | [8-K](/filings/0001753926-26-001341.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001753926-26-001341 | | 2026-07-06 | 20:30 ET | [8-K](/filings/0001753926-26-001137.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-26-001137 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001753926-26-000600.md), filed Mar 31, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/f8e2a333-94f8-4620-8500-73cd79f3e57e) ## About the filer - CIK: 840715 - Tickers: CLRO - Exchange: Nasdaq - SIC code: 3661 Telephone & Telegraph Apparatus - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.